No Significant Changes of Glycemic Control and Renal Function in Patients with Advanced-Stage Diabetic Kidney Disease by Switching from Linagliptin to Teneligliptin

PURPOSE: We compared the efficacy of teneligliptin versus linagliptin for glycemic control and renoprotection in patients with advanced-stage diabetic kidney disease. PATIENTS AND METHODS: Changes in the glycated hemoglobin (HbA1c), fasting blood glucose concentration, urine albumin-to-creatinine ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirai, Keiji, Nonaka, Hiroaki, Ueda, Moeka, Morino, Junki, Kaneko, Shohei, Minato, Saori, Mutsuyoshi, Yuko, Yanai, Katsunori, Ishii, Hiroki, Matsuyama, Momoko, Kitano, Taisuke, Aomatsu, Akinori, Miyazawa, Haruhisa, Ito, Kiyonori, Ueda, Yuichiro, Ookawara, Susumu, Morishita, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354772/
https://www.ncbi.nlm.nih.gov/pubmed/34393541
http://dx.doi.org/10.2147/POR.S314409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354772/
https://www.ncbi.nlm.nih.gov/pubmed/34393541
http://dx.doi.org/10.2147/POR.S314409

Ejemplares similares